A detailed history of Prosight Management, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 470,000 shares of GH stock, worth $13.6 Million. This represents 2.79% of its overall portfolio holdings.

Number of Shares
470,000
Holding current value
$13.6 Million
% of portfolio
2.79%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $8.05 Million - $12.6 Million
470,000 New
470,000 $9.7 Million
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $2.48 Million - $3.45 Million
-41,700 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $2.61 Million - $4.6 Million
41,700 New
41,700 $2.66 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.95B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.